Compound Detail
CHEMBL4289678
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4289678 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FNYGWXSATBUBER-SANMLTNESA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
462.6
MW (Da)
4.86
ALogP
4
HBA
1
HBD
67.2
PSA (Ų)
0.55
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 7.16
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Isocitrate dehydrogenase [NADP] cytoplasmic CHEMBL2007625 | IC50 | 7.16 | 6.73 | 70.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Isocitrate dehydrogenase [NADP] cytoplasmic | IC50 | = | 70.0 | nM | 7.16 | Inhibition of IDH1 R132H mutant (unknown origin) assessed as reduction in conver... | 29670690 |
| Isocitrate dehydrogenase [NADP] cytoplasmic | IC50 | = | 497.0 | nM | 6.3 | Inhibition of IDH1 R132C mutant in human HT1080 cells assessed as reduction in 2... | 29670690 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 29670690 | 10.1021/acsmedchemlett.7b00421 | Isocitrate dehydrogenase [NADP] cytoplasmic | 2 |
| 29670690 | 10.1021/acsmedchemlett.7b00421 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine